Aviptadil primary endpoint is a dont care as it relates to
Aviptadil primary endpoint is a dont care as it relates to CD12.
I tried to highlight the aviptadil results because of the deaths in the aviptadil trial placebo arm:
31 patients
9 deaths between day zero and day 28
21 additional deaths between day 28 and day 77
Massive deaths outside of the 28 day trial period.
Although the above numbers are drawn directly from Figure 5 on page 181 of the BRPA Jan 27 sec filing, the numbers are obviously corrupted.
The listed numbers underneath the Figure 5 data plot do not match the data plot.
Regardless of the mismatch, the Figure 5 dataplot indicates at least twice as many aviptadil placebo patients died after day 28 as before day 28.
In this case aviptadil is massively effective, but aviptadil does not reduce mortality inside of 28 days.
The FDA is no doubt confounded with this situation and will take a minimum of weeks to sort it out for aviptadil and provide direction.
Why does RLFTF/NeuroRx/BRPA face this situation?
Perhaps it is because the SOC has managed to extend the lifespan of critical patients, but only by about a month or two.
A month or two is enough to totally screw up CD12.
This delayed critical covid death could explain why the CD12 overall mortality is only 22%. The patients are not dying until later than 28 days.
A totally confounding situation for all involved.
However, if CD12 placebo 28 day mortality is 30% and trial deaths inside 28 days are reduced from the 87 total deaths already reported, then leronlimab efficacy relative to placebo climbs even higher.
If the SOC has moved covid deaths mostly outside of 28 days, that is a tremondously confounding factor for interpreting the results of CD12 for both CYDY as well as the FDA. And that could lead to delays.
7
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A New Dawn in App Creation You ever think about a world where creating an app is as straightforward as chatting with an old buddy? Well, that future's knocking at the door, courtesy of Appy Pie. They're ruffling feathers with a shiny new U.S. patent promising just that—apps whipped into shape by a bit of chitchat with their AI-powered platform. It's got folks scratching...
Continue Reading
Fashion with a Punch: Nailah Thorbourne's New Venture You'd think from the way the fashion industry's been humming along that someone would've cracked the code on shapewear a long time ago, right? But alas, it takes Nailah Thorbourne to step out of Brick & Lace's spotlight and into this shapely market with Vlair Shapewear. Apparently, what most overlooked in comfort, she...
Continue Reading
Four-Time Top Workplace Champ You want to talk consistency? Let's talk about AHN Healthcare@Home pulling in that Pittsburgh Top Workplace award four years running. It's no small feat, especially in the healthcare sector where employee burnout isn't just a buzzword—it's a daily challenge. How did a home health and hospice outfit like AHN land this honor? Well, it's all...
Continue Reading
Primrose Schools Delivers a New Era in Child Education Sitting at a crossroads between the tactile charm of hands-on learning and the inevitable march of digital literacy, Primrose Schools has unveiled something that might just rock the boat in early education: their new Balanced Learning® App. This move by Primrose comes at a crucial time when many parents are...
Continue Reading
Desert Resort Management in Labor Hot Seat Alright, here's a twist that might make your coffee spill—Desert Resort Management, Inc. is caught in a legal whirlwind in Riverside County. The heavy hitters at Blumenthal Nordrehaug Bhowmik De Blouw LLP have slapped a lawsuit right in their face, alleging some grimy labor practices. They're claiming that the company wasn't...
Continue Reading
Supporting Breast Cancer Awareness When a coconut water brand shifts to pink, it's not just about changing colors—it's a signal of commitment. Every October, the world paints itself pink to stand against breast cancer, and Once Upon a Coconut is no different. This year, they're diving headfirst into Breast Cancer Awareness Month with their limited-edition pink cans, all...
Continue Reading
Celina Graves Breaks New Ground on GoLive Streamers You'd think television capture all the talent buzz, but nope. Celina Graves, known from her semifinalist run on America's Got Talent, is diving into new waters by joining GoLive Streamers. She's stirring up the scene by making her performances more personal, stretching beyond the flatness of your typical TV appearance....
Continue Reading
Looks like Schneider Electric is diving headfirst into the choppy waters of utility management with its latest tech showcase at WEFTEC 2026. And trust me, the timing couldn't be more spot-on. With North America's water and wastewater systems groaning under the weight of aging infrastructure and cybersecurity threats, it’s about time someone brought something fresh to...
Continue Reading
Perkins Ditches the Phones, Sparks True Connection No doubt about it, folks—Perkins Restaurant & Bakery has cooked up something special to bring families back to the table. Not just for pancakes or pies this time, but for a little classic game action with their limited-edition Mahjong set. Love it or leave it, this is Perkins tapping into the magic of togetherness...
Continue Reading
You don't need a crystal ball to see J.P. Morgan's playing the long game by teaming up with Thunes. In this world, where cash is digital and the reach is global, it's all about speed and scale—brushing elbows with the right partners makes all the difference. Sometimes it's about knowing when to hitch your wagon to a reliable workhorse, especially when global commerce is...
Continue Reading
Top 5 Most Recently Viewed Articles
Gordon E. Davies Named Senior Vice President Midwest Institutional Trust Company (MITC) has recently appointed Gordon E. Davies as its Senior Vice President and Head of Benefit Payments. With a strong background in institutional trust services, Davies brings extensive experience in banking and technology solutions to this crucial position. Dedicated to Innovation and...
Continue Reading
Recent Breakthroughs in ADC Candidates at the ASCO Annual Meeting The ASCO Annual Meeting showcased promising clinical data from Duality Bio, presenting new developments in ADC candidates. These advancements signal hope for patients battling advanced cancers. Duality Bio (HKEX: 9606.HK) brought to light findings from two significant trials involving their B7H3 ADC...
Continue Reading
Transformational Leadership at PROACTIS SA In a recent shift within PROACTIS SA, notable governance changes have taken place, marking a new chapter for the company. The departure of Stephen Line from his roles as Director, Chairman, and Chief Executive Officer has paved the way for fresh leadership aimed at steering PROACTIS SA towards greater heights. Appointment of...
Continue Reading
Aptum Welcomes Jaime Konzelman as Chief Revenue Officer Aptum, a leading provider of hybrid cloud and managed services, has appointed Jaime Konzelman as its new Chief Revenue Officer. In this crucial role, she will help to shape Aptum's go-to-market strategy while managing sales, partnerships, and marketing efforts. The objective is clear: to empower customers to fully...
Continue Reading
Cryptocurrency Rally Amid Market Sentiment Shift Recently, leading cryptocurrencies have shown remarkable resilience, rallying despite challenges posed by hawkish Federal Reserve minutes. Bitcoin, Ethereum, Dogecoin, and XRP are positioning themselves in a market landscape where investor sentiment transitions from fear to neutrality. Key Market Movements Bitcoin reemerged...
Continue Reading